Mohammad S. Rostami

Array ( [id] => 4072365 [patent_doc_number] => 06069150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents' [patent_app_type] => 1 [patent_app_number] => 9/142058 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2212 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069150.pdf [firstpage_image] =>[orig_patent_app_number] => 142058 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4292704 [patent_doc_number] => 06235782 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Method for treating a patient with neoplasia by treatment with a platinum coordination complex' [patent_app_type] => 1 [patent_app_number] => 9/190830 [patent_app_country] => US [patent_app_date] => 1998-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 24 [patent_no_of_words] => 9867 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235782.pdf [firstpage_image] =>[orig_patent_app_number] => 190830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421946 [patent_doc_number] => 06225325 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Use of alkylated iminosugars to treat multidrug resistance' [patent_app_type] => 1 [patent_app_number] => 9/189177 [patent_app_country] => US [patent_app_date] => 1998-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10405 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225325.pdf [firstpage_image] =>[orig_patent_app_number] => 189177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407056 [patent_doc_number] => 06271266 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Use of idebenone and analogues against .beta. amyloid induced cytotoxicity' [patent_app_type] => 1 [patent_app_number] => 9/180463 [patent_app_country] => US [patent_app_date] => 1998-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4525 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271266.pdf [firstpage_image] =>[orig_patent_app_number] => 180463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4157088 [patent_doc_number] => 06103767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Physiologically active substances TKR1785\'s, process for the preparation thereof, and microbe' [patent_app_type] => 1 [patent_app_number] => 9/142689 [patent_app_country] => US [patent_app_date] => 1998-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5435 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103767.pdf [firstpage_image] =>[orig_patent_app_number] => 142689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4237602 [patent_doc_number] => 06166008 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Treatment of schizophrenia with ampakines and neuroleptics' [patent_app_type] => 1 [patent_app_number] => 9/179341 [patent_app_country] => US [patent_app_date] => 1998-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12089 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/166/06166008.pdf [firstpage_image] =>[orig_patent_app_number] => 179341 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4272450 [patent_doc_number] => 06245797 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease' [patent_app_type] => 1 [patent_app_number] => 9/179349 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9850 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245797.pdf [firstpage_image] =>[orig_patent_app_number] => 179349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234769 [patent_doc_number] => 06117862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Model and method for angiogenesis inhibition' [patent_app_type] => 1 [patent_app_number] => 9/169735 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4082 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117862.pdf [firstpage_image] =>[orig_patent_app_number] => 169735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4305052 [patent_doc_number] => 06187804 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-13 [patent_title] => 'Antibiotic compounds' [patent_app_type] => 1 [patent_app_number] => 9/168293 [patent_app_country] => US [patent_app_date] => 1998-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31611 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/187/06187804.pdf [firstpage_image] =>[orig_patent_app_number] => 168293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4154368 [patent_doc_number] => 06124322 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-26 [patent_title] => 'Intravenous form of thalidomide for treating immunological diseases' [patent_app_type] => 1 [patent_app_number] => 9/166953 [patent_app_country] => US [patent_app_date] => 1998-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1410 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/124/06124322.pdf [firstpage_image] =>[orig_patent_app_number] => 166953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4171910 [patent_doc_number] => 06140370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-31 [patent_title] => 'Stabilized alkyd based compositions containing halopropynl compounds' [patent_app_type] => 1 [patent_app_number] => 9/157861 [patent_app_country] => US [patent_app_date] => 1998-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5471 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/140/06140370.pdf [firstpage_image] =>[orig_patent_app_number] => 157861 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4384442 [patent_doc_number] => 06262116 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-17 [patent_title] => 'Transcription therapy for cancers' [patent_app_type] => 1 [patent_app_number] => 9/154672 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 30 [patent_no_of_words] => 17097 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/262/06262116.pdf [firstpage_image] =>[orig_patent_app_number] => 154672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406712 [patent_doc_number] => 06271240 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'Methods for improved regulation of endogenous dopamine in prolonged treatment of opioid addicted individuals' [patent_app_type] => 1 [patent_app_number] => 9/152834 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6953 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/271/06271240.pdf [firstpage_image] =>[orig_patent_app_number] => 152834 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134447 [patent_doc_number] => 06121310 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Aflatoxin contamination inhibitor and aflatoxin contamination-inhibiting method' [patent_app_type] => 1 [patent_app_number] => 9/145299 [patent_app_country] => US [patent_app_date] => 1998-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3959 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121310.pdf [firstpage_image] =>[orig_patent_app_number] => 145299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141463 [patent_doc_number] => 06060498 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Composition containing antitumor agent' [patent_app_type] => 1 [patent_app_number] => 9/125813 [patent_app_country] => US [patent_app_date] => 1998-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1493 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060498.pdf [firstpage_image] =>[orig_patent_app_number] => 125813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1286156 [patent_doc_number] => 06638949 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-10-28 [patent_title] => 'Prevention of adhesions and excessive scar formation using angiogenesis inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/139375 [patent_app_country] => US [patent_app_date] => 1998-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 4626 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/638/06638949.pdf [firstpage_image] =>[orig_patent_app_number] => 09139375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1575306 [patent_doc_number] => 06469033 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-22 [patent_title] => 'Use of 1-hydroxy-2-pyridones for the treatment of skin diseases' [patent_app_type] => B1 [patent_app_number] => 09/077191 [patent_app_country] => US [patent_app_date] => 1998-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2819 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 296 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/469/06469033.pdf [firstpage_image] =>[orig_patent_app_number] => 09077191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134554 [patent_doc_number] => 06121318 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Mite and tick control for reptiles' [patent_app_type] => 1 [patent_app_number] => 9/137981 [patent_app_country] => US [patent_app_date] => 1998-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2278 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121318.pdf [firstpage_image] =>[orig_patent_app_number] => 137981 [rel_patent_id] =>[rel_patent_doc_number] =>)